cisapride has been researched along with Diffuse Cutaneous Systemic Sclerosis in 1 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At baseline conditions IDDM and PSS patients exhibited reduced gastric peristalsis and delayed emptying compared to controls." | 2.71 | Prokinetic therapy: what can be measured by gastric scintigraphy? ( Folwaczny, C; Linke, R; Meier, M; Muenzing, W; Schnell, O; Tatsch, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Linke, R | 1 |
| Meier, M | 1 |
| Muenzing, W | 1 |
| Folwaczny, C | 1 |
| Schnell, O | 1 |
| Tatsch, K | 1 |
1 trial available for cisapride and Diffuse Cutaneous Systemic Sclerosis
| Article | Year |
|---|---|
Prokinetic therapy: what can be measured by gastric scintigraphy?
Topics: Adult; Aged; Cisapride; Diabetes Mellitus, Type 1; Female; Gastric Emptying; Gastrointestinal Agents | 2005 |